公开(公告)号：US20230235024A1

公开(公告)日：2023-07-27

申请号：US17865364

申请日：2022-07-14

Applicant: Amgen Inc.

Inventor： Zhimei DU ,  Pranhitha REDDY ,  Randal B. BASS ,  Feng HE ,  William C. FANSLOW, III ,  Yuling ZHANG ,  Da REN ,  Randall R. KETCHEM

IPC: C07K16/00

CPC classification number: C07K16/00 ,  C07K2317/41 ,  C07K2317/52 ,  C07K2317/524 ,  C07K2317/14 ,  C07K2319/30

Abstract: The present invention relates to variant Fc-containing molecules, such as antibodies and Fc-fusion molecules, having glycosylation characteristics favorable to large-scale production of therapeutic molecules containing such variant Fc.

公开(公告)号：US20170022285A1

公开(公告)日：2017-01-26

申请号：US15289797

申请日：2016-10-10

Applicant: AMGEN INC.

Inventor： Courtney BEERS ,  Jason C. O'NEILL ,  Ian FOLTZ ,  Randall R. KETCHEM ,  Julia C. PIASECKI

IPC: C07K16/28

CPC classification number: C07K16/2878 ,  A61K45/06 ,  A61K2039/505 ,  C07K2317/21 ,  C07K2317/33 ,  C07K2317/41 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/565 ,  C07K2317/71 ,  C07K2317/74 ,  C07K2317/75 ,  C07K2317/76 ,  C07K2317/77 ,  C07K2317/94

Abstract: Antigen binding proteins that activate GITR are provided. Nucleic acids encoding the antigen binding proteins and vectors and cells containing such nucleic acids are also provided. The antigen binding proteins have value in therapeutic methods in which it is useful to stimulate GITR signaling, thereby inducing or enhancing an immune response in a subject. Accordingly, the antigen binding proteins have utility in a variety of immunotherapy treatments, including treatment of various cancers and infections.

Abstract translation: 提供激活GITR的抗原结合蛋白。 还提供了编码抗原结合蛋白的核酸和含有此类核酸的载体和细胞。 抗原结合蛋白在治疗方法中具有价值，其中它可用于刺激GITR信号传导，从而诱导或增强受试者的免疫应答。 因此，抗原结合蛋白具有多种免疫治疗方法的用途，包括治疗各种癌症和感染。